Viral infection induces de novo lesions of coronary allograft vasculopathy through a natural killer cell-dependent pathway

American Journal of Transplantation

Volumn 9, Issue 11, 2009, Pages 2479-2484

  Graham, J A ^a   Wilkinson, R A ^b   Hirohashi, T ^a   Chase, C M ^a   Colvin, R B ^c   Madsen, J C ^a   Fishman, J A ^b   Russell, P S ^a  

^a Department of Surgery

^b Transplant Infectious Diseases Program   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Allograft arteriopathy; Cardiac transplant; Coronary artery disease; Graft rejection; NK cells; Vasculopathy; Viral

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CARDIAC ALLOGRAFT VASCULOPATHY; CONTROLLED STUDY; HEART TRANSPLANTATION; LYMPHOCYTE DEPLETION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ANIMALS; ARENAVIRIDAE INFECTIONS; B-LYMPHOCYTES; CORONARY DISEASE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HOMEODOMAIN PROTEINS; IMMUNOCOMPROMISED HOST; KILLER CELLS, NATURAL; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 70350134486     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02801.x     Document Type: Article

References (33)

1. Kass M, Haddad H. Cardiac allograft vasculopathy: Pathology, prevention and treatment. Curr Opin Cardiol 2006 21 : 132 137.
2. Valantine H. Cardiac allograft vasculopathy after heart transplantation: Risk factors and management. J Heart Lung Transplant 2004 23 (5 Suppl S187 193.
3. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD, Wagner CR. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995 92 : 205 211.
4. Ventura HO, Mehra MR, Smart FW, Stapleton DD. Cardiac allograft vasculopathy: Current concepts. Am Heart J 1995 129 : 791 799.
5. Koskinen PK, Kallio EA, Tikkanen JM, Sihvola RK, Hayry PJ, Lemstrom KB. Cytomegalovirus infection and cardiac allograft vasculopathy. Transpl Infect Dis 1999 1 : 115 126.
6. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989 261 : 3561 3566.
7. Lemstrom K, Koskinen P, Krogerus L, Daemen M, Bruggeman C, Hayry P. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 1995 92 : 2594 2604.
8. Maier S, Tertilt C, Chambron N et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001 7 : 557 562.
9. Russell PS, Chase CM, Sykes M, Ito H, Shaffer J, Colvin RB. Tolerance, mixed chimerism, and chronic transplant arteriopathy. J Immunol 2001 167 : 5731 5740.
10. Uehara S, Chase CM, Kitchens WH et al. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005 175 : 3424 3430.
11. Snell GD, Jackson RB. Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines. J Natl Cancer Inst 1958 21 : 843 877.
12. Bukowski JF, Biron CA, Welsh RM. Elevated natural killer cell-mediated cytotoxicity, plasma interferon, and tumor cell rejection in mice persistently infected with lymphocytic choriomeningitis virus. J Immunol 1983 131 : 991 996.
13. Brehm MA, Daniels KA, Ortaldo JR, Welsh RM. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo. J Immunol 2005 174 : 6663 6671.
14. Karlhofer FM, Ribaudo RK, Yokoyama WM. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 1992 358 : 66 70.
15. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973 16 : 343 350.
16. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994 144 : 260 274.
17. Armstrong AT, Strauch AR, Starling RC, Sedmak DD, Orosz CG. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 1997 63 : 941 947.
18. Kitchens WH, Chase CM, Uehara S et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007 7 : 2675 2682.
19. Welsh RM, Brubaker JO, Vargas-Cortes M, O'Donnell CL. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J Exp Med 1991 173 : 1053 1063.
20. Andoniou CE, Andrews DM, Degli-Esposti MA. Natural killer cells in viral infection: More than just killers. Immunol Rev 2006 214 : 239 250.
21. Oberg L, Johansson S, Michaelsson J et al. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur J Immunol 2004 34 : 1646 1653.
22. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Ann Rev Immunol 1999 17 : 189 220.
23. Lanier LL. Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 2008 8 : 259 268.
24. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells.[see comment]. Nat Immunol 2006 7 : 507 516.
25. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 : 727 729.
26. Lodoen MB, Lanier LL. Viral modulation of NK cell immunity. Nat Rev Microbiol 2005 3 : 59 69.
27. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells.[see comment]. Nat Immunol 2001 2 : 255 260.
28. Andrews DM, Andoniou CE, Scalzo AA et al. Cross-talk between dendritic cells and natural killer cells in viral infection. Mol Immunol 2005 42 : 547 555.
29. Granucci F, Zanoni I, Ricciardi-Castagnoli P. Natural killer (NK) cell functions can be strongly boosted by activated dendritic cells (DC).[comment]. Eur J Immunol 2006 36 : 2819 2820.
30. Ferlazzo G, Pack M, Thomas D et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004 101 : 16606 16611.
31. Andoniou CE, van Dommelen SL, Voigt V et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005 6 : 1011 1019.
32. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002 195 : 327 333.
33. Zuniga EI, Liou LY, Mack L, Mendoza M, Oldstone MB. Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections. Cell Host Microbe 2008 4 : 374 386.